2019 France HIV/AIDS Testing Market in Hospitals, Blood Banks, Commercial Labs-- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures

This new 795-page report from contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic Technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
 
Market Segmentation Analysis

- Review of five POC market segments, including their dynamics, trends, structure,
  size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for major infectious disease tests
  by market segment:

- Physician Offices/Group Practices    
- Emergency Rooms       
- Ambulatory Care Centers        
- Surgery Centers 
- Birth Centers

Sales and Market Share Analysis

- Market shares of major infectious disease diagnostic reagent and instrument suppliers.

Current and Emerging Products

- Analysis of infectious disease diagnostic tests performed in POC testing locations.
- Review of leading infectious disease testing analyzers, both currently marketed and
  those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging Technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing coagulation
   testing Technologies and products, by assay.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, joint ventures,
  and new products in R&D.

Strategic Recommendations

- Specific opportunities for new infectious disease testing instruments and reagent systems with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.

Methodology
This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and proprietary data files.


I. Introduction
II. AIDS/HIV Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. France: Market Size, Growth and Major Suppliers
Sales and Market Shares
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatch/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako




List Of Tables



Table 1. Major Companies Developing or Marketing AIDS Tests
Table 2. France: HIV or HIV-1/2/Combo Test Volume and Sales Forecast by Market Segment
Table 3. France: HIV Ag Test Volume and Sales Forecast by Market Segment
Table 4. France: Western Blot/Other Confirmatory Tests Volume and Sales Forecast
by Market Segment
Table 5. France: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Table 6. France: AIDS Diagnostics Market by Major Supplier
Table 7. France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

2020 Germany Microbiology Lab and POC Market for 100 Tests: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

This presents a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key German market trends; reviews

USD 3500 View Report

2020 France Microbiology Lab and POC Market for 100 Tests: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

This presents a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key French market trends; reviews

USD 3500 View Report

2019-2024 France HIV/AIDS Diagnostic Testing Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot, Other Confirmatory Tests

This report presents detailed analyses of the AIDS diagnostics market in France. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV, NAT, Western Blot, HTLV-I/II and other

USD 1850 View Report

France HIV/AIDS Diagnostic Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares and Country Segment Forecasts, 2019-2023

This report presents detailed analyses of the AIDS diagnostics market in France. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV, NAT, Western Blot, HTLV-I/II and other

USD 1850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available